Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.370
+0.002 (0.46%)
Apr 29, 2026, 9:37 AM EDT - Market open
Jupiter Neurosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.64 | -2.44 | -4.78 | -4.96 | -4.2 | |
| Other Amortization | 0.77 | 0.1 | 0.02 | 0.56 | 0.08 | |
| Stock-Based Compensation | 2.42 | 1.84 | 1.2 | 0.82 | 1.43 | |
| Other Operating Activities | -0.06 | -0.84 | 0.74 | 0.78 | 0.18 | |
| Change in Accounts Receivable | -0 | - | - | - | 0.13 | |
| Change in Inventory | -0.16 | - | - | - | - | |
| Change in Accounts Payable | 0.24 | -0.15 | 0.16 | -0.06 | -0.16 | |
| Change in Unearned Revenue | 0 | - | - | - | - | |
| Change in Other Net Operating Assets | 0.02 | -2.42 | 2.18 | 1.61 | 0.81 | |
| Operating Cash Flow | -5.41 | -3.91 | -0.48 | -1.25 | -1.74 | |
| Short-Term Debt Issued | 5.58 | 0.14 | 0.39 | 0.98 | 0.53 | |
| Total Debt Issued | 5.58 | 0.14 | 0.39 | 0.98 | 0.53 | |
| Short-Term Debt Repaid | -0.15 | -2.36 | - | - | - | |
| Total Debt Repaid | -0.15 | -2.36 | - | - | - | |
| Net Debt Issued (Repaid) | 5.43 | -2.22 | 0.39 | 0.98 | 0.53 | |
| Issuance of Common Stock | - | 0.15 | 0.06 | - | 1.33 | |
| Other Financing Activities | - | 9.73 | - | - | - | |
| Financing Cash Flow | 5.43 | 7.65 | 0.45 | 0.98 | 1.86 | |
| Net Cash Flow | 0.02 | 3.74 | -0.04 | -0.27 | 0.12 | |
| Cash Interest Paid | 0.04 | 0.15 | 0.03 | 0.08 | 0 | |
| Levered Free Cash Flow | -2.31 | -2.92 | -3.12 | -0.83 | 0.25 | |
| Unlevered Free Cash Flow | -2.27 | -2.81 | -3 | -0.92 | 0.24 | |
| Change in Working Capital | 0.11 | -2.57 | 2.35 | 1.55 | 0.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.